Hinge Health (HNGE) Sheds 15% After Swinging to Net Loss

We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Hinge Health, Inc. (NYSE:HNGE) is one of the worst-performing stocks on Wednesday.

Hinge Health ended a three-day winning streak on Wednesday, slashing 15.06 percent to finish at $45.39 apiece as investor sentiment was dampened by a disappointing earnings performance, having swung to a net loss in the third quarter of the year.

In its financial statement, Hinge Health, Inc. (NYSE:HNGE) said it fell to a net loss attributable to shareholders of $1.8 million from a $72,000 net income in the same period last year, amid higher operating expenses and loss from operations.Hinge Health (HNGE) Sheds 15% After Swinging to Net Loss

Operating loss stood at $6.1 million, or a 56.4 percent jump from the $3.9 million in the same comparable period.

Revenues, on the other hand, jumped by 53 percent to $154.2 million from $100.6 million.

Looking ahead, Hinge Health, Inc. (NYSE:HNGE) remained upbeat about its outlook for the fourth quarter and full-year 2025.

For 2025, the company expects revenues to hit $572 million to $574 million, or a 47 percent year-on-year growth at the midpoint.

For the fourth quarter, revenues are expected to grow by 33 percent year-on-year to a range of $155 million to $157 million.

While we acknowledge the potential of HNGE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

View Comments